טוען...
Prostacyclin Production Following In Vitro Mixing of Normal With Hemolytic-Uremic-Syndrome Serum
Serum from patients with the hemolytic-uremic syndrome (HUS) usually has a diminished ability to support the production of prostacyclin (prostaglandin [PG] I(2)). An impaired ability to produce this potent antiaggregatory substance could account for the thrombotic microangiopathy that is characteris...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
1988
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1026241/ https://ncbi.nlm.nih.gov/pubmed/3043896 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|